Role of the Renin-Angiotensin System and Aldosterone on Cardiometabolic Syndrome

Aldosterone facilitates cardiovascular damage by increasing blood pressure and through different mechanisms that are independent of its effects on blood pressure. In this respect, recent evidence involves aldosterone in the pathogenesis of metabolic syndrome. Although this relationship is complex, t...

Full description

Saved in:
Bibliographic Details
Main Authors: P. Stiefel, A. J. Vallejo-Vaz, S. García Morillo, J. Villar
Format: Article
Language:English
Published: Wiley 2011-01-01
Series:International Journal of Hypertension
Online Access:http://dx.doi.org/10.4061/2011/685238
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832545327407693824
author P. Stiefel
A. J. Vallejo-Vaz
S. García Morillo
J. Villar
author_facet P. Stiefel
A. J. Vallejo-Vaz
S. García Morillo
J. Villar
author_sort P. Stiefel
collection DOAJ
description Aldosterone facilitates cardiovascular damage by increasing blood pressure and through different mechanisms that are independent of its effects on blood pressure. In this respect, recent evidence involves aldosterone in the pathogenesis of metabolic syndrome. Although this relationship is complex, there is some evidence suggesting that different factors may play an important role, such as insulin resistance, renin-angiotensin-aldosterone system, oxidative stress, sodium retention, increased sympathetic activity, levels of free fatty acids, or inflammatory cytokines and adipokines. In addition to the classical pathway by which aldosterone acts through the mineralocorticoid receptors leading to sodium retention, aldosterone also has other mechanisms that influence cardiovascular tissue remodelling. Finally, overweight and obesity promote the adrenal secretion of aldosterone, increasing the predisposition to type 2 diabetes mellitus. Further studies are needed to better establish therapeutic strategies that act on the blockade of mineralocorticoid receptor in the treatment and prevention of cardiovascular diseases related to the excess of aldosterone and the metabolic syndrome.
format Article
id doaj-art-b42a6ec0d861462892828a5162ec1e22
institution Kabale University
issn 2090-0392
language English
publishDate 2011-01-01
publisher Wiley
record_format Article
series International Journal of Hypertension
spelling doaj-art-b42a6ec0d861462892828a5162ec1e222025-02-03T07:26:09ZengWileyInternational Journal of Hypertension2090-03922011-01-01201110.4061/2011/685238685238Role of the Renin-Angiotensin System and Aldosterone on Cardiometabolic SyndromeP. Stiefel0A. J. Vallejo-Vaz1S. García Morillo2J. Villar3Unidad clínico-experimental de Riesgo Vascular (UCERV-UCAMI), IBIS. Hospital Universitario Virgen del Rocío, SAS, Universidad de Sevilla, CSIC Avenida, 41011 Sevilla, SpainUnidad clínico-experimental de Riesgo Vascular (UCERV-UCAMI), IBIS. Hospital Universitario Virgen del Rocío, SAS, Universidad de Sevilla, CSIC Avenida, 41011 Sevilla, SpainUnidad clínico-experimental de Riesgo Vascular (UCERV-UCAMI), IBIS. Hospital Universitario Virgen del Rocío, SAS, Universidad de Sevilla, CSIC Avenida, 41011 Sevilla, SpainUnidad clínico-experimental de Riesgo Vascular (UCERV-UCAMI), IBIS. Hospital Universitario Virgen del Rocío, SAS, Universidad de Sevilla, CSIC Avenida, 41011 Sevilla, SpainAldosterone facilitates cardiovascular damage by increasing blood pressure and through different mechanisms that are independent of its effects on blood pressure. In this respect, recent evidence involves aldosterone in the pathogenesis of metabolic syndrome. Although this relationship is complex, there is some evidence suggesting that different factors may play an important role, such as insulin resistance, renin-angiotensin-aldosterone system, oxidative stress, sodium retention, increased sympathetic activity, levels of free fatty acids, or inflammatory cytokines and adipokines. In addition to the classical pathway by which aldosterone acts through the mineralocorticoid receptors leading to sodium retention, aldosterone also has other mechanisms that influence cardiovascular tissue remodelling. Finally, overweight and obesity promote the adrenal secretion of aldosterone, increasing the predisposition to type 2 diabetes mellitus. Further studies are needed to better establish therapeutic strategies that act on the blockade of mineralocorticoid receptor in the treatment and prevention of cardiovascular diseases related to the excess of aldosterone and the metabolic syndrome.http://dx.doi.org/10.4061/2011/685238
spellingShingle P. Stiefel
A. J. Vallejo-Vaz
S. García Morillo
J. Villar
Role of the Renin-Angiotensin System and Aldosterone on Cardiometabolic Syndrome
International Journal of Hypertension
title Role of the Renin-Angiotensin System and Aldosterone on Cardiometabolic Syndrome
title_full Role of the Renin-Angiotensin System and Aldosterone on Cardiometabolic Syndrome
title_fullStr Role of the Renin-Angiotensin System and Aldosterone on Cardiometabolic Syndrome
title_full_unstemmed Role of the Renin-Angiotensin System and Aldosterone on Cardiometabolic Syndrome
title_short Role of the Renin-Angiotensin System and Aldosterone on Cardiometabolic Syndrome
title_sort role of the renin angiotensin system and aldosterone on cardiometabolic syndrome
url http://dx.doi.org/10.4061/2011/685238
work_keys_str_mv AT pstiefel roleofthereninangiotensinsystemandaldosteroneoncardiometabolicsyndrome
AT ajvallejovaz roleofthereninangiotensinsystemandaldosteroneoncardiometabolicsyndrome
AT sgarciamorillo roleofthereninangiotensinsystemandaldosteroneoncardiometabolicsyndrome
AT jvillar roleofthereninangiotensinsystemandaldosteroneoncardiometabolicsyndrome